Gavin Lewis
Senior Vice President, Head of Value and Access, Novartis
Gavin Lewis is listed as Senior Vice President, Head of Value and Access, Novartis. Gavin is scheduled to speak at World EPA Congress Europe 2027 on 2 March 2027.
Compiled from published conference agendas; not yet confirmed by Gavin. Is this you? Claim this profile.
About
Gavin originally was an undergraduate in Economics and Politics, before working for the Scottish Government as an Economist in the Health Department. After obtaining an MSc in Health Economics from York University, he joined the Pharmaceutical industry for Roche in the UK where he worked for over 10 years developing and leading their Health Economics and Pricing department. He has experience in leading over 50 Health Technology appraisals with NICE, SMC and also prepared Roche’s response to the Value Based Pricing consultation and contributed to the development of the NICE Guide to Methods for Technology Appraisal. Gavin left the UK to start a new role for Roche as Head of Pricing and Market Access for Region Europe, where he has developed a new team with responsibilities for strategic pricing, payer marketing and real world evidence for Europe. At AstraZeneca Gavin led the Global Oncology Market Access team supporting the launch of several new brands. Gavin joined Amgen as Vice Presid
Upcoming
World EPA Congress Europe 2027 2 March 2027 – 3 March 2027
- Chair's opening remarks Chair · 2 March 2027
- Panel: Staying Agile in a Shifting Landscape: Rethinking Global Market Access in the MFN era Panellist · 3 March 2027
Spoke alongside
People who have shared a session with Gavin at events on B2DB.
- Iroda Jurabekova Executive Director, Global Market Access, Oncology · Boehringer Ingelheim 1 shared session
- Jorge Arellano Senior Vice President, Global Head PAVE, Pricing, Access, Value & Evidence · BioMarin 1 shared session